Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
By Tami Luhby, CNN (CNN) — The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients paying more for the medications. The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx
Continue Reading